Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)
CUSIP: 22978P106
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.001 par value per share
- Shares outstanding
- 43,411,663
- Total 13F shares
- 17,351,508
- Share change
- +5,949,039
- Total reported value
- $11,856,298
- Price per share
- $0.68
- Number of holders
- 46
- Value change
- +$3,983,649
- Number of buys
- 18
- Number of sells
- 20
Quarterly Holders Quick Answers
What is CUSIP 22978P106?
CUSIP 22978P106 identifies CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 22978P106:
Top shareholders of CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bleichroeder LP |
13D/G
13F
|
Company |
10%
|
6,127,662
|
$5,269,789 | $0 | 19 Mar 2025 | |
| Michael J. Fox |
3/4/5
|
Director |
—
mixed-class rows
|
1,148,800
mixed-class rows
|
$3,036,000 | — | 05 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.3%
|
2,315,862
|
$2,109,750 | — | 31 Mar 2025 | |
| Cameron Gray |
3/4/5
|
Director |
—
class O/S missing
|
687,049
|
$1,896,255 | — | 14 Jun 2022 | |
| Mark E. Strome |
13D/G
|
— |
5%
|
2,166,242
|
$1,862,968 | $0 | 14 Nov 2022 | |
| Slate Path Capital LP |
13D/G
|
— |
1.4%
|
918,836
|
$790,199 | $0 | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
693,890
|
$632,264 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
1.5%
|
635,203
|
$578,671 | — | 31 Mar 2025 | |
| Robertson Stephens Wealth Management, LLC |
13F
|
Company |
1.1%
|
478,500
|
$435,914 | — | 31 Mar 2025 | |
| Anish Suri |
3/4/5
|
PRESIDENT AND CSO |
—
mixed-class rows
|
285,638
mixed-class rows
|
$374,361 | — | 05 Jun 2024 | |
| Sigma Planning Corp |
13F
|
Company |
0.75%
|
326,260
|
$297,223 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.75%
|
324,351
|
$295,484 | — | 31 Mar 2025 | |
| ADVISORY RESEARCH INC |
13F
|
Company |
0.59%
|
257,225
|
$234,332 | — | 31 Mar 2025 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.47%
|
203,578
|
$185,460 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.45%
|
196,629
|
$179,129 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.44%
|
189,753
|
$172,865 | — | 31 Mar 2025 | |
| Daniel R. Passeri |
3/4/5
|
CHIEF EXECUTIVE OFFICER, Director |
—
mixed-class rows
|
614,578
mixed-class rows
|
$169,515 | — | 21 Mar 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.3%
|
128,284
|
$116,867 | — | 31 Mar 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.27%
|
117,262
|
$107,000 | — | 31 Mar 2025 | |
| Chicago Partners Investment Group LLC |
13F
|
Company |
0.21%
|
90,302
|
$69,388 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.14%
|
61,313
|
$55,856 | — | 31 Mar 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.1%
|
42,925
|
$39,105 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.09%
|
36,946
|
$33,658 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.08%
|
34,778
|
$31,683 | — | 31 Mar 2025 | |
| Texas Capital Bank Wealth Management Services Inc |
13F
|
Company |
0.08%
|
33,102
|
$30,156 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
28,692
|
$26,139 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.06%
|
26,944
|
$24,546 | — | 31 Mar 2025 | |
| Navalign, LLC |
13F
|
Company |
0.06%
|
25,000
|
$22,775 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
20,077
|
$18,290 | — | 31 Mar 2025 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.05%
|
20,000
|
$18,000 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
14,401
|
$13,119 | — | 31 Mar 2025 | |
| StoneX Group Inc. |
13F
|
Company |
0.03%
|
14,058
|
$12,807 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.03%
|
13,572
|
$12,364 | — | 31 Mar 2025 | |
| SeaCrest Wealth Management, LLC |
13F
|
Company |
0.03%
|
13,000
|
$11,843 | — | 31 Mar 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.02%
|
10,390
|
$9,465 | — | 31 Mar 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.02%
|
10,000
|
$9,111 | — | 31 Mar 2025 | |
| Beacon Pointe Advisors, LLC |
13F
|
Company |
0.02%
|
10,000
|
$9,110 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
6,029
|
$5,492 | — | 31 Mar 2025 | |
| Gleason Group, Inc. |
13F
|
Company |
0.01%
|
6,000
|
$5,466 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
3,874
|
$3,529 | — | 31 Mar 2025 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0.01%
|
3,500
|
$3,189 | — | 31 Mar 2025 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0.01%
|
2,550
|
$2,323 | — | 31 Mar 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
2,395
|
$2,000 | — | 31 Mar 2025 | |
| Golden State Wealth Management, LLC |
13F
|
Company |
0%
|
2,000
|
$1,822 | — | 31 Mar 2025 | |
| Tidemark, LLC |
13F
|
Company |
0%
|
1,500
|
$1,367 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,051
|
$958 | — | 31 Mar 2025 | |
| Physician Wealth Advisors, Inc. |
13F
|
Company |
0%
|
1,006
|
$917 | — | 31 Mar 2025 | |
| MATHER GROUP, LLC. |
13F
|
Company |
0%
|
1,000
|
$911 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
715
|
$651 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
680
|
$618 | — | 31 Mar 2025 |
Institutional Holders of Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) as of Q2 2025
As of 30 Jun 2025,
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,351,508 shares.
The largest 10 holders included
Bleichroeder LP, GC Wealth Management RIA, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Robertson Stephens Wealth Management, LLC, BlackRock, Inc., BANK OF AMERICA CORP /DE/, UBS Group AG, ADVISORY RESEARCH INC, and STIFEL FINANCIAL CORP.
This page lists
46
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
49
Q2 2025 holders
46
Holder diff
-3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.